Evidence map›Paper›PMID 18353181›Full record

ArticleVirology journal2008

HDAC inhibitors stimulate viral transcription by multiple mechanisms.

Lata Balakrishnan, Barry Milavetz

Open access · goldAbstract read
In one paragraph

Article in Virology journal, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Epigenetic Analysis of SV40 Minichromosomes.Current protocols in microbiology · 2017
    Article
  7. Article
  8. Article
  9. Dual agarose magnetic (DAM) ChIP.BMC research notes · 2009
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Lata BalakrishnanDepartment of Biochemistry and Molecular Biology, University of North Dakota, Grand Forks, North Dakota, USA. lbalakrishnan@medicine.nodak.edu
Barry Milavetz
University of North Dakota · US

Funding

Hyperacetylation of Biologically Active SV40 ChromatinR15GM074811 · NIGMS · UNIVERSITY OF NORTH DAKOTA · PI MILAVETZ, BARRY I · 2006 to 2006
$209k
NIGMS NIH HHS 1R15GM074811-01A1NIGMS NIH HHS R15 GM074811
6 · The paper itself

Abstract

backgroundThe effects of histone deacetylase inhibitor (HDACi) treatment on SV40 transcription and replication were determined by monitoring the levels of early and late expression, the extent of replication, and the percentage of SV40 minichromosomes capable of transcription and replication following treatment with sodium butyrate (NaBu) and trichostatin A (TSA).

resultsThe HDACi treatment was found to maximally stimulate early transcription at early times and late transcription at late times through increased numbers of minichromosomes which carry RNA polymerase II (RNAPII) transcription complexes and increased occupancy of the transcribing minichromosomes by RNAPII. HDACi treatment also partially relieved the normal down-regulation of early transcription by T-antigen seen later in infection. The increased recruitment of transcribing minichromosomes at late times was correlated to a corresponding reduction in SV40 replication and the percentage of minichromosomes capable of replication.

conclusionThese results suggest that histone deacetylation plays a critical role in the regulation of many aspects of an SV40 lytic infection.

Indexed as

Histone Deacetylase InhibitorsAnimalsButyratesCell LineChromosomesGene Expression Regulation, ViralHydroxamic AcidsRNA Polymerase IISimian virus 40Transcription, GeneticViral ProteinsVirus ReplicationButyratesHistone Deacetylase InhibitorsHydroxamic AcidsRNA Polymerase IItrichostatin AViral Proteins

Identifiers

PMID18353181
PMCPMC2291040
OpenAlexW2168098507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.